Imvax was founded by a neurosurgeon striving to change the landscape of treatment for GBM patients to extend both the duration and quality of their lives. The Imvax approach is “antigen-agnostic” and our proprietary methodology provides the immune system with the patient’s own unique multi-antigen tumor profile, telling the body where and what to fight. The resulting systemic, long-lasting immune response specifically ta...
Imvax was founded by a neurosurgeon striving to change the landscape of treatment for GBM patients to extend both the duration and quality of their lives. The Imvax approach is “antigen-agnostic” and our proprietary methodology provides the immune system with the patient’s own unique multi-antigen tumor profile, telling the body where and what to fight. The resulting systemic, long-lasting immune response specifically targets the tumor’s entire antigen profile, while simultaneously nullifying its immune-silencing ability.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.